Advertisement

Topics

Companies Related to "CYP2D6 Genotype on the Clinical Effect of Tamoxifen" [Most Relevant Company Matches] RSS

23:16 EDT 16th August 2018 | BioPortfolio

Here are the most relevant search results for "CYP2D6 Genotype on the Clinical Effect of Tamoxifen" found in our extensive corporate database of over 50,000 company records.

Showing "CYP2D6 Genotype Clinical Effect Tamoxifen" Companies 1–25 of 5,000+

Relevant

Ana-Gen Technologies, Inc

Anagen Technologies, Inc. is located in Atlanta, Georgia. We strive to provide high-quality, Genetic/Genotype analysis, and contract molecular biology services to pharmaceutical, research and clinical markets worldwide, and have been doing so since our inception 1994. Our custom services include Gene Synthesis, DNA Sequencing, Site Directed Mutagenesis, Nucleic Acid Purification, Genotype/Genetic ...


Eminent effect

The eminent effect is a consultancy aiming to stand out from the crowd in tackling many of today’s people and business challenges. The company offers organisation specific training, development, sales/marketing and interim management solutions not off the shelf packages.Primarily working within the NHS, Pharmaceutical and Biotechnology sectors, the eminent effect personnel can offer experience g...

Sangamo BioSciences, Inc.

Sangamo BioSciences, Inc. is focused on the research and development of novel DNA-binding proteins for therapeutic gene regulation and modification. The most advanced ZFP Therapeutic(TM) development program is currently in a Phase 2b clinical trial for evaluation of safety and clinical effect in patients with diabetic neuropathy and a Phase 2 trial in ALS. Sangamo also has two Phase 1 clinical tri...


Orasi Medical

Orasi Medical develops products to measure the effect of neurological treatments and track the progression of neurological disorders. Pharmaceutical companies use Orasi Index(TM), the company's flagship product, to reduce costs and improve clinical development of neurological treatments. Orasi's high-resolution measurement of brain function provides a robust, non-invasive and reproducible measure ...

Essentys AB

Essentys AB is an innovative biotech company developing therapeutics for the treatment and prevention of diseases in the elderly.The Company is currently focused on the development of its lead product ES 1 in osteoporosis, in which proof of concept has been obtained in clinical phase II studies. ES 1 constitutes a completely new approach to the treatment and prevention of osteoporosis. The data su...

Spaulding Clinical

Spaulding Clinical (www.spauldingclinical.com) is a Phase 1 Clinical Pharmacology Research Unit and Electrocardiography Core Lab located in West Bend, Wisconsin offering a full range of services. The company has extensive experience conducting TQT studies, first-in-human studies, multiple rising dose, bioavailability and bioequivalence, drug interaction, a...

Protalex, Inc.

Protalex, Inc. is a clinical stage biopharmaceutical company that is developing a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases, including but not limited to, rheumatoid arthritis. Protalex’s lead product PRTX-100, which is formulated with a highly-purified form of staphylococcal protein A, has completed a Phase 1b...

Probably Relevant

Numab

Founded in 2011, Numab discovers and develops innovative antibody-based therapeutics. Applying proprietary rabbit-based antibody discovery and engineering technology, Numab generates highly potent and stable antibody Fv fragments, which serve as building blocks to create mono- or bi-specific antibody fragment-based therapeutics with tailored pharmacokineti...

CogState Ltd

CogState Ltd specializes in the development and commercialization of rapid, computerized tests of cognition (brain function). The tests are sold to pharmaceutical, biotechnology, nutraceutical and functional food companies to quantify the effect of drugs or other interventions on human subjects participating in clinical trials.

Tosk Inc.

Tosk was founded in 1998 to discover new drugs for genetic diseases and cancer. The original technology, in part licensed from Stanford University,StealthGene and Targeted Gene Delivery technologies. In the process, Tosk discovered and perfected the Optimizing Marketed Drugs side-effect-reducing drugs.Tosk's current drug discovery and development efforts focus on applying the OMD approach to disco...

Genometrix

Genometrix offers online point-and-click genomic services that enable our partners to efficiently design and perform experiments, monitor progress, receive and interpret results, all over a private Internet link. By partnering with Genometrix, scientists can rapidly discover complex connections between genetic profiles, disease risk and therapeutic response, without leaving their desk.Our comprehe...

ClinicalStudyDataRequest.com

ClinicalStudyDataRequest.com is the industry leader in global clinical trial data transparency. Its multi-sponsor Request System provides a secure process for researchers to request access to global clinical trial data through a publicly available website. An Independent Review Panel and process overseen by the Wellcome Trust review data requests received ...

Happy Hour Effect

Happy Hour Effect LLC

BioMedica Inc.

Oxford BioMedica (LSE: OXB) is a biopharmaceutical company specialising in the development of novel gene-based therapeutics with a focus on the areas of oncology and neurotherapy. The Company was established in 1995 as a spin out from Oxford University, and is listed on the London Stock Exchange.Oxford BioMedica’s products use genes as the mediators of a therapeutic effect and/or immune response...

Selcia Limited & Convergence Pharmaceuticals Limited

Convergence Pharmaceuticals is an independent biotechnology company focused on the development of novel analgesics with potentially commercially attractive efficacy, responder-rate and side effect profiles. The Company, led by CEO Clive Dix, was formed in October 2010 following the acquisition of certain neuroscience clinical assets from GlaxoSmithKline (...

VEP Healthcare, Inc.

VEP Healthcare began providing emergency medical management services in 1981. In the years since, the organization’s expertise has expanded into hospitalist services, intensive care, clinical decision units, telehealth, and surgicalist services. Today, the owners of VEP – the company’s physicians, advanced practice clinicians, and corporate ...

Cytogen

Cytogen is a specialty pharmaceutical company dedicated to advancing the treatment and care of cancer patients by building, developing, and commercializing a portfolio of oncology products. The Company's specialized sales force currently markets QUADRAMET® (samarium Sm-153 lexidronam injection), PROSTASCINT® (capromab pendetide), and SOLTAMOX™ (tamoxifen citrate) to the U.S. oncology market. Q...

Worldwide Clinical Trials

Accelerate Your Development Program with Pinpoint Therapeutic Focus and Complete Spectrum of Services Worldwide Clinical Trials is a global CRO that provides full-service drug development services to the pharmaceutical and biotechnology industries.   As one of the most innovative and scientifically-driven contract research organizations, we offer exceptionally strong clinical trial m...

Viral Genetics

Viral Genetics is developing immune-based therapies for the treatment of HIV/AIDS and other infectious, autoimmune, and immunological deficiency disorders. The Company’s primary product candidate is VGV-1, an investigational therapy for the treatment of HIV/AIDS that has demonstrated an antiviral effect in clinical trials with an apparent immunological mechanism of action. VGV-1 is a suspension ...

Imposter Research

IMPOSTER is the name of a medical research study of patients with muscle symptoms while taking cholesterol lowering therapies called statins. Several important findings from this study have been published and have raised questions about the safety of statin therapy for patients with muscle complaints. This website was developed to address those questions and to share what is known about statin mu...

Berzelius Clinical Research Center

Berzelius Clinical Research Center AB (BCRC) is a unique Site Management Organisation specialised in clinical conduct of Phase 0/I/II studies and the ideal partner for Contract Research Organisations (CRO) and pharmaceutical companies. BCRC has a hospital based well-equipped clinical pharmacology unit. Having a fully trained critical care staff enables easy setup of invasive techniques and procedu...

CryoTherapy

CryoCath catheters look and handle like heat-based catheters, but do not destroy tissue in the same manner. They remove heat from target tissue, slowing cellular activity. Both the amount of heat and the speed at which it is removed can be controlled, allowing for a transient or permanent electrical effect in target cells.The mechanisms of CryoTherapy are largely seen at the cellular level, where ...

Corgenix Medical Corp.

Corgenix is a leader in the development and manufacturing of specialized diagnostic kits for immunology disorders, vascular diseases and bone and joint disorders, including the world’s only non-blood-based test for aspirin effect. Corgenix diagnostic products are commercialized for use in clinical laboratories throughout the world. The company currently ...

Kedalion Therapeutics, Inc.

Kedalion Therapeutics is a venture-backed, clinical-stage biotechnology company whose mission is to bring to market transformative topical ophthalmic therapies for new and existing indications. Kedalion’s proprietary AcuStream platform technology delivers topical drugs to the eye in a precise and accurate manner that enables comparable effect with up ...


More From BioPortfolio on "CYP2D6 Genotype on the Clinical Effect of Tamoxifen"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks